Experimental study on pathological features of pulmonary fibrosis in type 2 diabetes mellitus
付庭吕,李宁,熊锐,刘博昊,何如愿,李国瑞,耿庆
DOI: https://doi.org/10.3760/cma.j.cn421213-20211013-00792
2022-01-01
Abstract:Objective:To investigate the pathological features of pulmonary fibrosis in patients with type 2 diabetes mellitus (T2DM).Methods:Totally, 27 cases patients with T2DM 2 diabetes mellitus were selected as the DM group, and 17 patients without T2DM in the same period served as the control group (control group) at the Department of Thoracic Surgery, Renmin Hospital of Wuhan University from June 2020 to October 2021. Then the pathological features of pulmonary fibrosis in the two groups were analyzed after the complete cases information and lung surgical tissue were collected. Chi-square test was used for count data and
t test was used for measurement data for statistical analysis.
Results:The fasting plasma glucose (FPG) in the DM group was higher than in the control group [(7.16±1.74) vs. (4.88±0.51) mmol/L,
t=5.006,
P<0.01], and there was no significant difference in the rest parameters. Pulmonary function showed that the forced expiratory volume in one second to the forced vital capacity (FEV1/FVC) in the DM group was higher than in the control group [(80.05±5.77)% vs. (74.23±3.93)%,
t=3.092,
P<0.05]. The percentage of predicted value in the forced vital capacity (FVC%pred), percentage of predicted value in the forced expiratory volume in one second (FEV1%pred), percentage of predicted value in maximal ventilation volume (MVV%pred), and diffusing capacity for carbon monoxide (DLco) in the DM group were lower than in the control group [(96.65±12.71)% vs. (108.85±10.35)%, (88.20±9.78)% vs. (99.08±8.03)%, (85.24±14.21)% vs. (97.11±10.42)%, (17.61±3.47) ml/(mmHg·min) vs. (20.74±3.70) ml/(mmHg·min);
t=2.867, 3.241, 2.125, 2.215,
P<0.05, 1 mmHg=0.133 kPa], and the changes in lung function indexes were consistent with restrictive ventilatory dysfunction. The pathological staining showed that the DM group had obvious alveolar septum thickening, pulmonary vascular basement lamina thickening, a large number of inflammatory cell infiltration and characteristic fibrotic changes compared to the control group, and the positive rate of fibrosis in the DM group was significantly higher than in the control group [85.19%(23/27) vs. 17.65% (3/17),
χ2=19.68,
P<0.01]. The protein markers of Vimentin, Collagen1, and the mRNA expression levels of alpha-smooth muscle actin (α-SMA), Vimentin, Collagen1, Collagen3 of pulmonary fibrosis in the DM group were significantly higher than in the control group (
t=12.520, 6.304,
P<0.01;
t=6.017, 32.710, 13.740, 8.110,
P<0.01). The immunofluorescence staining showed that the accumulation of pulmonary fibrosis markers in the DM group increased significantly around the pulmonary vessels.
Conclusion:Patients with T2DM can induce pulmonary fibrosis under long-term hyperglycemia stimulation, and fibrosis markers mainly accumulate around the pulmonary vessels.